Detection of anti–type 3 muscarinic acetylcholine receptor autoantibodies in the sera of Sjögren's syndrome patients by use of a transfected cell line assay
Open Access
- 5 August 2004
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 50 (8) , 2615-2621
- https://doi.org/10.1002/art.20371
Abstract
Objective Sjögren's syndrome (SS) is an autoimmune disease affecting primarily the salivary and lacrimal glands, leading to dry mouth and dry eyes. Recent studies have suggested that autoantibodies reactive with the type 3 muscarinic acetylcholine receptors (M3Rs) expressed on salivary and lacrimal gland cells may be highly specific for SS. To test this hypothesis, we constructed a cell line expressing the human M3R gene in order to screen for anti‐M3R autoantibodies in sera from SS patients. Methods Complementary DNA encoding the open‐reading frame (ORF) of the human M3R gene was amplified, ligated into the pcDNA5/FRT/V5‐His‐TOPO TA vector, and then used to transform Escherichia coli bacteria. Plasmid DNA containing the M3R ORF with the correct orientation was transfected into Flp‐In Chinese hamster ovary (CHO) cells using Flp recombinase–mediated site‐specific recombination. An M3R‐transfected CHO cell line, selected and propagated in hygromycin, was used to detect anti‐M3R autoantibodies in SS patient and healthy control sera by flow cytometry. Results Testing of sera for the presence of anti‐M3R autoantibodies bound to CHO‐transfected cells revealed the presence of anti‐M3R autoantibodies in SS patients (9 of 11) but not in healthy controls (0 of 11). Although the anti‐M3R autoantibodies detected in patient sera were of multiple isotypes, the most consistently detected were IgG1, IgG3, and IgA. Conclusion Using a newly constructed cell line expressing human M3R, anti‐M3R autoantibodies were easily detected in sera from SS patients. These autoantibodies were skewed toward the IgG1, IgG3, and IgA isotypes, probably recognizing a tertiary epitope created by extracellular domains of the receptor protein. Anti‐M3R autoantibodies represent a highly promising clinical marker for the identification of SS.Keywords
Funding Information
- National Institute of Dental and Craniofacial Research (DE-05152, DE-55304)
- National Institute of Allergy and Infectious Diseases (AI-47483)
This publication has 10 references indexed in Scilit:
- Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus GroupAnnals of the Rheumatic Diseases, 2002
- Progress in Understanding Autoimmune Exocrinopathy Using the Non-obese Diabetic Mouse: An UpdateCritical Reviews in Oral Biology & Medicine, 2002
- IL‐4‐Dependent Effector Phase in Autoimmune Exocrinopathy as Defined by the NOD.IL‐4‐Gene Knockout Mouse Model of Sjögren's SyndromeScandinavian Journal of Immunology, 2001
- Autoantibodies in Primary Sjögren's Syndrome: New Insights into Mechanisms of Autoantibody Diversification and Disease PathogenesisAutoimmunity, 2001
- Evidence for antimuscarinic acetylcholine receptor antibody-mediated secretory dysfunction in NOD miceArthritis & Rheumatism, 2000
- Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndromeArthritis & Rheumatism, 2000
- Muscarinic receptor subtypes in subpopulations of human blood mononuclear cells as analyzed by RT-PCR techniqueJournal of Neuroimmunology, 1996
- Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome.Annals of the Rheumatic Diseases, 1996
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982